Clinical Trials

    Showing 1 - 7 of 7 Neal Kleiman

    ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement

    Status: Open Not Enrolling

    Investigator: Neal Kleiman

    Study Coordinator: Deena Victor

    Phone: 713.441.4536

    Brief Summary: To evaluate safety and effectiveness of the ACURATE Transfemoral Aortic Valve System for transcatheter aortic valve replacement (TAVR) in subjects with severe native aortic stenosis who are indicated for TAVR. Detailed Description: ... Read more >

    CoreValve® Expanded

    Status: Open Not Enrolling

    Investigator: Neal Kleiman

    Study Coordinator: Deena Victor

    Phone: 713.441.4536

    The primary objective of the study is to evaluate the safety and effectiveness of the Medtronic CoreValve® System (MCS) in a subset of subjects excluded from the U.S. Extreme Risk Pivotal Trial population due to one or more additional co-morbidities,... Read more >

    Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial (CLASP IID/IIF)

    Status: Enrolling

    Investigator: Neal Kleiman

    Study Coordinator: Deena Victor

    Phone: 713.441.4536

    Brief Summary: To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Valve Repair System in patients with degenerative mitral regurgitation (DMR) who have been determined to be at prohibitive risk for mitral valve surgery by ... Read more >

    Evolut EXPAND TAVR II Pivotal Trial

    Status: Enrolling

    Investigator: Neal Kleiman

    Study Coordinator: Deena Victor

    Phone: 713.441.4536

    Brief Summary: Obtain safety and effectiveness data to support indication expansion for the Medtronic TAVR System to include patients with moderate, symptomatic AS. Detailed Description: Multi-center, international, prospective, randomized study... Read more >

    Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function (PROTECT IV)

    Status: Enrolling

    Investigator: Neal Kleiman

    Study Coordinator: Padmaja Naik

    Phone: 713.441.7386

    The purpose of this study is to assess if using the Impella® CP (or Impella® 2.5) device during high-risk PCI in patients with reduced left-sided heart function will result in an improvement in symptoms, heart function and health after a heart proced... Read more >

    SURTAVI

    Status: Open Not Enrolling

    Investigator: Neal Kleiman

    Study Coordinator: Tia McGaughy

    Phone: 346.238.4576

    The purpose of the study is to investigate the safety and efficacy of transcatheter aortic valve implantation (TAVI) in patients with severe, symptomatic Aortic Stenosis (AS) at intermediate surgical risk by randomizing patients to either Surgical Ao... Read more >

    Transcatheter Mitral Valve Replacement With the Medtronic Intrepid TMVR System in Patients With Severe Symptomatic Mitral Regurgitation. (APOLLO)

    Status: Enrolling

    Investigator: Neal Kleiman

    Study Coordinator: Tia McGaughy

    Phone: 346.238.4576

    Brief Summary: Multi-center, global, prospective, non-randomized, interventional, pre-market trial. All subjects enrolled with receive the study device. Inclusion Criteria: Moderate to severe or severe symptomatic mitral regurgitation Local sit... Read more >